Our goal is to understand the physiopathology and to discover new treatments for rare disorders involving the PIK3CA/AKT/mTOR pathway.
Our research is supported by the European Commission (European Research Council Starting grant acronym PAPA_Study and European Research Council Proof of Concept grant, acronym CureTheCloves) but also by several Foundations.
The laboratory is located at the Necker Hospital (Paris). The team belongs to the INEM (Institut Necker Enfants Malades) and the Renal division.
The best of scientific research committed to PatientsProfesseur Sébastien Candel
Congratulations to Quitterie for the prize “Grandes Avancées Françaises en Biologie” from the Académie des Sciences!
On Tuesday, June 25, 2019, the Academy of Sciences invited young researchers / first authors, having contributed to major French scientific advances in biology, to present their results at the Institut de France. The Laureates were awarded with a medal and a prize of...read more
The #COSY project (Cure Overgrowth SYndromes) will support fundamental research, drugs repositioning, creation of an OS department at Necker, development of new imaging modalities, state of the art genetic testing, 1st registry, promote socialization, education and...read more
Guillaume Canaud receives the Jean Hamburger 2018 Grand Prix of Medicine from the City of Paris for the quality of his research and the major breakthrough on Cloves Syndrome. This prize, created in 1993, distinguishes a researcher aged under 45 who has made a...read more